HOME >> BIOLOGY >> NEWS
Stevens and Connecticut Innovations agree to investment of $500,000 in SPOC Inc.

HOBOKEN, N.J. -- Stevens Institute of Technology and Connecticut Innovations (CI), the states quasi-public authority responsible for technology investing and innovation development, today announced that they had completed an agreement for a seed-stage investment of $500,000 in Stevens Proof of Concept Inc. (SPOC), a Technogenesis Company founded at Stevens Institute of Technology. CI made this investment through its Connecticut BioSeed Fund.

SPOC was formed in July 2005 at Stevens by Vice President Helena S. Wisniewski in the Office of University Research and Enterprise Development, along with Dr. Norman Marcus, a leader in pain management, and a team of Stevens undergraduate students in biomedical engineering. SPOC has developed a proprietary point-of-care medical diagnostic system, consisting of a medical device and methodology that pinpoint the specific myofascial (muscle) trigger points causing pain. The patent pending device is the first use of electroneural stimulation for diagnostic purposes.

SPOCs diagnostic system will benefit patients by helping to eliminate treatments that prove to be ineffective, such as surgical procedures, and by allowing physicians to locate and treat more effectively muscles that generate pain.

Since approximately 100 million people in the United States suffer from chronic pain and approximately 80 percent of Americans suffer from some form of pain in their lifetime, the potential market for such a system is enormous.

"SPOCs diagnostic device is disruptive it will revolutionize neck and back pain diagnosis and treatment practices," said Dr. Wisniewski, who launched SPOC and serves as a member of the board. Wisniewski added, "We are very pleased to enter into a relationship with CI, an organization committed to commercializing technologies for the public good, which is aligned with Stevens Technogenesis paradigm."

SPOCs CEO, Dr. Vikki Hazelwood, said, "The entrepreneurial environment within Ste
'"/>

Contact: Patrick A. Berzinski
pberzins@stevens.edu
201-216-5687
Stevens Institute of Technology
2-Apr-2007


Page: 1 2

Related biology news :

1. Stevens Center for Science Writings honors Edward O. Wilson with Green Book Award
2. Stevens, N.J. Sea Grant to host coastal management workshop
3. Stevens Davidson Laboratory acquires new research vessel
4. Stevens professor named an Early Career Principal Investigator
5. Stevens Disruptive Technologies Roundtable Series discusses SPOC
6. Stevens CSW begins list of 100 Greatest Science Books
7. Stevens and Monmouth Presidents to co-chair ASBPA National Scientific Shore and Beach Conference
8. Lee M. Silver to discuss new book, Challenging Nature, at Stevens
9. Stevens professor to speak during Princeton lecture series
10. Journalists to discuss scientific challenges in Stevens lecture
11. Stevens Professor Alan Blumberg to speak at New York Public Library

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Stevens and Connecticut Innovations agree investment SPOC Inc

(Date:5/16/2013)... Injectable nanoparticles developed at MIT may someday eliminate ... to constantly monitor their blood-sugar levels and inject ... to sense glucose levels in the body and ... thereby replacing the function of pancreatic islet cells, ... diabetes. Ultimately, this type of system could ensure ...
(Date:5/16/2013)... 2013 Integrated Biometrics patented LES (Light ... thin film transistor camera introduces Sherlock, a fingerprint ... in the smallest and lightest form factor available ... Mobile ID FAP 45, Certified scanner is highly ... and weight when compared to optical scanners. ...
(Date:5/16/2013)... entirety of an individual,s DNA is examined to look ... health problems is a massively useful technology for diagnosing ... problems if used incorrectly, say new recommendations from the ... today (16 May 2013) in the European Journal ... genome and on exome* sequencing and analysis are now ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2
(Date:5/17/2013)... 17, 2013  Cellular Biomedicine Group (OTCQB: CBMG) ... of the total projected enrollment required for its ... preliminary efficacy of the medical technology haMPC (Human ... (KOA). To date the trial has had no ... Phase I open label clinical research trial for ...
(Date:5/17/2013)... Health, Inc., a company developing natural compounds to address ... is today reporting top-line results from a Phase Ib ... drug-resistant epilepsy.  The data are being presented at the ... Dr. Steven Schachter , Harvard Medical ... In this study, INS001 appeared safe and well tolerated. ...
(Date:5/17/2013)... MD (PRWEB) May 17, 2013 ... of ezColony version 4.1, a versatile refinement to ... premier software solution, improves its advanced methodical management ... facilities with ezColony 4.1. The network-based platform provides ... conduct effective research. While continuing to emphasize streamlined ...
(Date:5/17/2013)... Darrington, WA (PRWEB) May 17, 2013 Tooth ... 5th graders showing active signs of the disease. The World ... children and nearly 100% of adults have cavities. What are ... Research is showing a strong connection between the oral ... why is this disease so rampant, yet it is also ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
Cached News: